New Zealand Pharmaceuticals & Biotech High Insider Buying

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

2 companies

Pacific Edge

Market Cap: NZ$347.7m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.28

-1.8%

166.7%

Rua Bioscience

Market Cap: NZ$12.6m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.035

20.7%

-22.2%